CHARACTERISTICS OF FILGOTINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS WHO ACHIEVE SUSTAINED CORTICOSTEROID-FREE REMISSION: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Taku Kobayashi  ¹     Axel Dignass  ²     Xavier Roblin  ³     Yasushi Fujitani  ⁴     Alessandra Oortwijn  ⁵     Corinne Jamoul  ⁶     Toshifumi Hibi    
¹ Kitasato University Kitasato Institute Hospital, Tokyo, Japan
² Agaplesion Markus Krankenhaus, Frankfurt/ Main, Germany
³ University Hospital of Saint-Étienne, Saint-Étienne, France
⁴ Gilead Sciences K.K., Tokyo, Japan
⁵ Galapagos NV, Leiden, Netherlands
⁶ Galapagos NV, Mechelen, Belgium

Topic
IBD

Session
IBD: We treat them all - but how? (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)